Evgenyi Shalaev
15Patents
3h-index
12Co-inventors
57Inventor score
Filing activity: Mar 12, 2001 → Apr 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10369190B2 | Non-protein clostridial toxin compositions | Emerging Cross-Sectional Technologies | 9 | Active |
| US7378408B2 | Methods of treatment and formulations of cephalosporin | Human Necessities | 8 | Expired |
| US6764993B2 | Use of o-vanillin and o-vanillin/trolox combinations | Human Necessities | 7 | Expired |
| US10973890B2 | Non-protein clostridial toxin compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US7939675B2 | Process for forming amorphous atorvastatin | Human Necessities | 3 | Active |
| US12144847B2 | Non-protein clostridial toxin compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10765629B2 | Solid complex, preparations and uses thereof | Human Necessities | 1 | Active |
| US9428455B2 | Process for annealing amorphous atorvastatin | Human Necessities | 0 | Active |
| US12171816B2 | Non-protein Clostridial toxin compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US9034913B2 | Process for annealing amorphous atorvastatin | Human Necessities | 0 | Active |
| US9056831B2 | Process for forming amorphous atorvastatin | Human Necessities | 0 | Active |
| US9932307B2 | Process for annealing amorphous atorvastatin | Human Necessities | 0 | Active |
| US12409211B2 | Non-protein Clostridial toxin compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US8258315B2 | Process for forming amorphous atorvastatin | Human Necessities | 0 | Active |
| US8686163B2 | Process for forming amorphous atorvastatin | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.